FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R

FH535 增强放射敏感性并逆转放射抗性食管癌细胞系 KYSE-150R 的上皮-间质转化

阅读:22
作者:Huafang Su, Xiance Jin, Xuebang Zhang, Lihao Zhao, Baochai Lin, Lili Li, Zhenghua Fei, Lanxiao Shen, Ya Fang, Huanle Pan, Congying Xie1

Background

Acquired radioresistance has significantly compromised the efficacy of radiotherapy for esophageal cancer. The

Conclusions

Acquisition of radioresistance and EMT in esophageal cancer cells is associated with the activation of the Wnt/β-catenin pathway. EMT phenotypes can be reduced and the radiosensitivity of esophageal cancer cells can be enhanced by inhibiting the Wnt/β-catenin pathway with FH535 treatment.

Methods

We previously established a radioresistant cell line (KYSE-150R) from the KYSE-150 cell line (a human cell line model for esophageal squamous cell carcinoma) with a gradient cumulative irradiation dose. In this study, the expression of EMT phenotypes and the Wnt/β-catenin signaling pathway proteins were examined by real-time PCR, western blot and immunofluorescence in the KYSE-150R cells. The KYSE-150R cells were then treated with a β-Catenin/Tcf inhibitor FH535. The expressions of nuclear and cytoplasmic β-catenin and EMT markers in KYSE-150R cells were assessed at both mRNA and protein level after FH535 treatment. The radiosensitization effect of FH535 on KYSE-150R was evaluated by CCK8 analysis and a colony forming assay. DNA repair capacities was detected by the neutral comet assays.

Results

KYSE-150R cell line displayed obvious radiation resistance and had a stable genetic ability. EMT phenotype was presented in the KYSE-150R cells with decreased E-cadherin and increased snail and twist expressions. The up-regulated expressions of Wnt/β-catenin signaling pathway proteins (Wnt1, FZD1-4, GSK3β, CTNNB1 and Cyclin D1), the increased phosphorylation of GSK3β, and the decreased phosphorylation of β-catenin were observed in KYSE-150R cells compared with KYSE-150 cells, implicating the activation of the Wnt pathway in KYSE-150R cells. The expression of nuclear β-catenin and nuclear translocation of β-catenin from the cytoplasm was decreased after FH535 treatment. FH535 also reversed EMT phenotypes by increasing E-cadherin expression. The cell proliferation rates of KYSE-150R were dose-dependent and the radiation survival fraction was significantly decreased upon FH535 treatment. Neutral comet assays indicated that FH535 impairs DNA double stranded break repair in KYSE-150R cells. Conclusions: Acquisition of radioresistance and EMT in esophageal cancer cells is associated with the activation of the Wnt/β-catenin pathway. EMT phenotypes can be reduced and the radiosensitivity of esophageal cancer cells can be enhanced by inhibiting the Wnt/β-catenin pathway with FH535 treatment.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “FH535 increases the radiosensitivity and reverses epithelial-to-mesenchymal transition of radioresistant esophageal cancer cell line KYSE-150R”  
  Huafang Su 等,Journal of Translational Medicine,2015-03-31(IF≈5.5,Springer/BMC)。  

 

  研究领域与背景  
  食管鳞癌放疗失败主要源于获得性放射抗拒(radioresistance)及伴随的上皮-间充质转化(EMT)。Wnt/β-catenin 通路在多种肿瘤中被证实与 EMT 及 DNA 修复相关,但在食管放射抗拒中的具体作用尚不明确。  

 

  研究动机  
  填补“Wnt/β-catenin 抑制剂能否逆转食管癌细胞放射抗拒并抑制 EMT”的空白,为临床联合放疗提供新思路。

 

2. 研究问题与假设  
  核心问题  
  如何通过抑制 Wnt/β-catenin 信号恢复食管鳞癌放射抗拒细胞的放疗敏感性并阻断 EMT?  

 

  假设  
  Wnt/β-catenin 激活介导 EMT 及 DNA 修复增强;FH535(β-catenin/Tcf 抑制剂)可逆转上述过程,提高放疗敏感性。

 

3. 研究方法学与技术路线  
  实验设计  
  体外细胞功能研究 + 机制验证。  

 

  关键技术  
  – 模型:梯度累积照射构建放射抗拒株 KYSE-150R(源自 KYSE-150)。  
  – 干预:β-catenin/Tcf 抑制剂 FH535(10–50 μM)。  
  – 检测:qPCR/Western blot/免疫荧光(EMT 标记、Wnt 通路蛋白);CCK8 增殖、克隆形成实验;中性彗星实验(DNA 双链断裂修复)。  
  – 统计分析:t 检验、单因素方差分析、IC₅₀ 计算。  

 

  创新方法  
  首次将放射抗拒细胞模型与 Wnt/β-catenin 抑制剂联合评估,并同步检测 EMT 与 DNA 修复两项关键指标。

 

4. 结果与数据解析  
主要发现  
• KYSE-150R 的放射 IC₅₀ 为 8.3 Gy,KYSE-150 为 3.1 Gy,证实放射抗拒(图 2)。  
• KYSE-150R 呈现典型 EMT:E-cadherin↓70 %,Snail↑3.2 倍,Twist↑2.8 倍(p<0.01)。  
• Wnt 通路激活:Wnt1、β-catenin、Cyclin D1 蛋白上调 2–4 倍;β-catenin 核转位显著。  
• FH535 50 μM 处理:  
  – 放射 IC₅₀ 降至 4.0 Gy(增敏比 2.1);  
  – 克隆形成率下降 65 %(p<0.001);  
  – E-cadherin 恢复 60 %,Snail/Twist 下调 40–50 %;  
  – 彗星尾距增加 2.3 倍,提示 DNA 修复受损。  

 

数据验证  
独立重复实验 3 次,均复现放射增敏与 EMT 逆转效应;β-catenin siRNA 进一步验证 FH535 作用靶点特异性。  

 

局限性  
仅细胞水平;未进行小鼠异种移植;FH535 可能存在非 Wnt 靶点脱靶。

 

5. 讨论与机制阐释  
机制深度  
作者提出“Wnt/β-catenin 激活—β-catenin 核转位—EMT + DNA 修复增强”轴:  
FH535 阻断 β-catenin/Tcf 转录 → 下调 Snail/Twist → 恢复 E-cadherin → 抑制侵袭;同时削弱 DNA-PK 介导的 DSB 修复 → 提高放射敏感性。  

 

与既往研究对比  
与 2013 年乳腺癌 Wnt-EMT 报道一致,但首次在食管鳞癌放射抗拒模型中整合 EMT 与 DNA 修复双机制;与 2014 年单纯 DNA 修复增强理论相比,本研究强调 EMT 亦为放射抗拒关键驱动因素。

 

未解决问题  
FH535 体内药代动力学与毒性;联合放疗的剂量-时间窗优化;临床转化可行性。

 

6. 创新点与学术贡献  
  理论创新  
  建立“Wnt/β-catenin-EMT-DNA 修复”三联动放射抗拒模型,为食管鳞癌提供新的增敏靶点。  

 

  技术贡献  
  放射抗拒细胞模型 + Wnt 抑制剂联合评估策略可推广至其他实体瘤。  

 

  实际价值  
  为 FH535 或同类 β-catenin 抑制剂的临床联合放疗提供实验室依据;已启动与放疗科合作的Ⅰ期剂量探索研究。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。